Last update 23 Mar 2025

ETS-006

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
ETS 006, ETS006
Target
TEAD x YAP1
Action
inhibitors
Mechanism
TEAD inhibitors(TEA domain transcription factors inhibitors), YAP1 inhibitors(Yes1 associated transcriptional regulator inhibitors)
Therapeutic Areas
NeoplasmsRespiratory DiseasesSkin and Musculoskeletal Diseases+ [1]
Active Indication
Solid tumorAdvanced Malignant Solid NeoplasmMalignant Pleural Mesothelioma+ [3]
Inactive Indication-
Originator Organization
ETERN Therapeutics Co., Ltd.ETERN Therapeutics Co., Ltd.
Active Organization
ETERN Therapeutics Co., Ltd.ETERN Therapeutics Co., Ltd.Wu Xi Yi Tuo Yi Yao Ke Ji You Xian Ze Ren Gong Si
Inactive Organization-
Drug Highest PhaseIND Approval
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

Related

100 Clinical Results associated with ETS-006
Login to view more data
100 Translational Medicine associated with ETS-006
Login to view more data
100 Patents (Medical) associated with ETS-006
Login to view more data
100 Deals associated with ETS-006
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Solid tumorIND Approval
China
Wu Xi Yi Tuo Yi Yao Ke Ji You Xian Ze Ren Gong Si
20 Mar 2025
Advanced Malignant Solid NeoplasmIND Approval
United States
ETERN Therapeutics Co., Ltd.ETERN Therapeutics Co., Ltd.
19 Dec 2024
Malignant Pleural MesotheliomaPreclinical
China
ETERN Therapeutics Co., Ltd.ETERN Therapeutics Co., Ltd.
22 Mar 2024
OsteosarcomaPreclinical
China
ETERN Therapeutics Co., Ltd.ETERN Therapeutics Co., Ltd.
22 Mar 2024
Squamous Cell Carcinoma of Head and NeckPreclinical
China
ETERN Therapeutics Co., Ltd.ETERN Therapeutics Co., Ltd.
22 Mar 2024
Triple Negative Breast CancerPreclinical
China
ETERN Therapeutics Co., Ltd.ETERN Therapeutics Co., Ltd.
22 Mar 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free